Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT).
Nakagawa Y, Nobuyoshi M, Yamaguchi T, Meguro T, Yokoi H, Kimura T, Hosoda S, Kanmatsuse K, Matsumori A, Sasayama S. Nakagawa Y, et al. Among authors: kanmatsuse k. Circ J. 2009 Jan;73(1):145-51. doi: 10.1253/circj.cj-08-0560. Epub 2008 Nov 21. Circ J. 2009. PMID: 19023152 Free article. Clinical Trial.
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction.
Kambara H, Kawai C, Kajiwara N, Niitani H, Sasayama S, Kanmatsuse K, Kodama K, Sato H, Nobuyoshi M, Nakashima M, et al. Kambara H, et al. Among authors: kanmatsuse k. Circulation. 1988 Oct;78(4):899-905. doi: 10.1161/01.cir.78.4.899. Circulation. 1988. PMID: 3139325 Clinical Trial.
A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: comparison with native t-PA. E6010 Study Group.
Kawai C, Yui Y, Hosoda S, Nobuyoshi M, Suzuki S, Sato H, Takatsu F, Motomiya T, Kanmatsuse K, Kodama K, Yabe Y, Minamino T, Kimata S, Nakashima M. Kawai C, et al. Among authors: kanmatsuse k. J Am Coll Cardiol. 1997 Jun;29(7):1447-53. doi: 10.1016/s0735-1097(97)00074-0. J Am Coll Cardiol. 1997. PMID: 9180103 Free article. Clinical Trial.
Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.
Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group. Yui Y, et al. Among authors: kanmatsuse k. Hypertens Res. 2004 Mar;27(3):181-91. doi: 10.1291/hypres.27.181. Hypertens Res. 2004. PMID: 15080377 Free article. Clinical Trial.
Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.
Yui Y, Sumiyoshi T, Kodama K, Hirayama A, Nonogi H, Kanmatsuse K, Origasa H, Iimura O, Ishii M, Saruta T, Arakawa K, Hosoda S, Kawai C. Yui Y, et al. Among authors: kanmatsuse k. Hypertens Res. 2004 Jul;27(7):449-56. doi: 10.1291/hypres.27.449. Hypertens Res. 2004. PMID: 15302980 Free article. Clinical Trial.
Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.
Nishigaki K, Yamazaki T, Kitabatake A, Yamaguchi T, Kanmatsuse K, Kodama I, Takekoshi N, Tomoike H, Hori M, Matsuzaki M, Takeshita A, Shimbo T, Fujiwara H; Japanese Stable Angina Pectoris Study Investigators. Nishigaki K, et al. Among authors: kanmatsuse k. JACC Cardiovasc Interv. 2008 Oct;1(5):469-79. doi: 10.1016/j.jcin.2008.08.002. JACC Cardiovasc Interv. 2008. PMID: 19463347 Free article. Clinical Trial.
Efficacy of calcium channel blocker in the secondary prevention of myocardial infarction--retrospective analysis of the 10-year prognosis or coronary thrombolysis-treated patients.
Tani S, Watanabe I, Nagao K, Kikushima K, Watanabe K, Anazawa T, Kawamata H, Tachibana E, Furuya S, Sasanuma T, Kushiro T, Kanmatsuse K. Tani S, et al. Among authors: kanmatsuse k. Circ J. 2004 Sep;68(9):853-9. doi: 10.1253/circj.68.853. Circ J. 2004. PMID: 15329508 Free article.
Relationship between the generation and the facilitated percutaneous coronary intervention in patients with acute myocardial infarction--analysis based on the fibrinolysis and subsequent transluminal trial--.
Watanabe I, Nagao K, Tani S, Ohba T, Arima K, Ohiwa K, Masuda N, Anazawa T, Kanmatsuse K, Kushiro T. Watanabe I, et al. Among authors: kanmatsuse k. Circ J. 2004 Dec;68(12):1117-22. doi: 10.1253/circj.68.1117. Circ J. 2004. PMID: 15564693 Free article. Clinical Trial.
332 results